| pubmed-article:20938959 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20938959 | lifeskim:mentions | umls-concept:C0012634 | lld:lifeskim |
| pubmed-article:20938959 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:20938959 | lifeskim:mentions | umls-concept:C0392360 | lld:lifeskim |
| pubmed-article:20938959 | lifeskim:mentions | umls-concept:C0205207 | lld:lifeskim |
| pubmed-article:20938959 | lifeskim:mentions | umls-concept:C0449295 | lld:lifeskim |
| pubmed-article:20938959 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:20938959 | pubmed:dateCreated | 2010-11-29 | lld:pubmed |
| pubmed-article:20938959 | pubmed:abstractText | The aim of this study was to evaluate the indications for, and outcomes and limitations of, OK-432 therapy in various otolaryngological cystic diseases. | lld:pubmed |
| pubmed-article:20938959 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20938959 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20938959 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20938959 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20938959 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20938959 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:20938959 | pubmed:issn | 1531-4995 | lld:pubmed |
| pubmed-article:20938959 | pubmed:author | pubmed-author:SuzukiYusukeY | lld:pubmed |
| pubmed-article:20938959 | pubmed:author | pubmed-author:AoyagiMasaruM | lld:pubmed |
| pubmed-article:20938959 | pubmed:author | pubmed-author:OhtaNobuoN | lld:pubmed |
| pubmed-article:20938959 | pubmed:author | pubmed-author:FukaseShigeru... | lld:pubmed |
| pubmed-article:20938959 | pubmed:author | pubmed-author:IshidaAkihiro... | lld:pubmed |
| pubmed-article:20938959 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20938959 | pubmed:volume | 120 | lld:pubmed |
| pubmed-article:20938959 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20938959 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20938959 | pubmed:pagination | 2193-6 | lld:pubmed |
| pubmed-article:20938959 | pubmed:meshHeading | pubmed-meshheading:20938959... | lld:pubmed |
| pubmed-article:20938959 | pubmed:meshHeading | pubmed-meshheading:20938959... | lld:pubmed |
| pubmed-article:20938959 | pubmed:meshHeading | pubmed-meshheading:20938959... | lld:pubmed |
| pubmed-article:20938959 | pubmed:meshHeading | pubmed-meshheading:20938959... | lld:pubmed |
| pubmed-article:20938959 | pubmed:meshHeading | pubmed-meshheading:20938959... | lld:pubmed |
| pubmed-article:20938959 | pubmed:meshHeading | pubmed-meshheading:20938959... | lld:pubmed |
| pubmed-article:20938959 | pubmed:meshHeading | pubmed-meshheading:20938959... | lld:pubmed |
| pubmed-article:20938959 | pubmed:meshHeading | pubmed-meshheading:20938959... | lld:pubmed |
| pubmed-article:20938959 | pubmed:meshHeading | pubmed-meshheading:20938959... | lld:pubmed |
| pubmed-article:20938959 | pubmed:meshHeading | pubmed-meshheading:20938959... | lld:pubmed |
| pubmed-article:20938959 | pubmed:meshHeading | pubmed-meshheading:20938959... | lld:pubmed |
| pubmed-article:20938959 | pubmed:meshHeading | pubmed-meshheading:20938959... | lld:pubmed |
| pubmed-article:20938959 | pubmed:meshHeading | pubmed-meshheading:20938959... | lld:pubmed |
| pubmed-article:20938959 | pubmed:meshHeading | pubmed-meshheading:20938959... | lld:pubmed |
| pubmed-article:20938959 | pubmed:meshHeading | pubmed-meshheading:20938959... | lld:pubmed |
| pubmed-article:20938959 | pubmed:meshHeading | pubmed-meshheading:20938959... | lld:pubmed |
| pubmed-article:20938959 | pubmed:meshHeading | pubmed-meshheading:20938959... | lld:pubmed |
| pubmed-article:20938959 | pubmed:meshHeading | pubmed-meshheading:20938959... | lld:pubmed |
| pubmed-article:20938959 | pubmed:meshHeading | pubmed-meshheading:20938959... | lld:pubmed |
| pubmed-article:20938959 | pubmed:meshHeading | pubmed-meshheading:20938959... | lld:pubmed |
| pubmed-article:20938959 | pubmed:meshHeading | pubmed-meshheading:20938959... | lld:pubmed |
| pubmed-article:20938959 | pubmed:meshHeading | pubmed-meshheading:20938959... | lld:pubmed |
| pubmed-article:20938959 | pubmed:meshHeading | pubmed-meshheading:20938959... | lld:pubmed |
| pubmed-article:20938959 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20938959 | pubmed:articleTitle | Treatments of various otolaryngological cystic diseases by OK-4321: its indications and limitations. | lld:pubmed |
| pubmed-article:20938959 | pubmed:affiliation | Department of Otolaryngology, Yamagata University School of Medicine, Yamagata, Japan. noohta@med.id.yamagata-u.ac.jp | lld:pubmed |
| pubmed-article:20938959 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20938959 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
